Plate Nº 16 · recorded November 9, 2026
Health & Medicine ResearchReported finding
Mouse study: Wireless implant normalized blood sugar without insulin
A three-centimeter wireless implant normalized blood sugar in diabetic, obese mice within 60 to 90 minutes, but kidney risks and human-scale dosing remain unresolved.
By Elena Vasquez4 min read703 words
In brief
- Researchers reported Oct. 22 in Science that the implant normalized high blood sugar in mice within 60 to 90 minutes.
- After six weeks, treated mice had lost up to 10% of body weight and showed lower triglycerides.
- The three-centimeter implant's automatic system ran for two weeks in eight mice.
- The catalyst remained able to convert glucose for up to three months under the mice's skin.
- People consume about 250 grams of carbohydrates daily, compared with 2 grams for mice.
By Elena Vasquez
An under-the-skin wireless implant brought high blood sugar back to normal within 60 to 90 minutes after researchers switched it on in mice with type 2 diabetes and obesity, according to researchers who reported their work Oct. 22 in Science.
What did the mouse study show?
After six weeks, the treated mice had lost up to 10% of their body weight and had lower triglycerides, a type of fat in the blood. The evidence remains limited to animals.
The catalyst remained able to convert glucose after up to three months under the mice's skin. The study did not establish how long the entire device would last.
In plain terms: The device produced quick glucose control in mice, while full-device longevity remains unproven.
How does the implant remove blood sugar?
The device measures 3 centimeters. It contains a catalyst made of gold flakes and platinum particles mounted on spongelike graphite. When electricity powers the catalyst, it converts glucose into gluconate, a compound that the kidneys can more easily flush from the body in urine.
The system removes glucose without added drugs, genes or living cells. Unlike insulin, which clears sugar from the bloodstream without ridding the body of it, the implant converts the glucose into material the kidneys can excrete. That is the key difference.
With less glucose available for energy, Martin Fussenegger and colleagues suspect the body turns more toward fat stores. The mice had higher blood levels of ketones, chemicals associated with fat breakdown. “This system kind of targets the root cause, which is the energy surplus by glucose in the body,” Fussenegger said.
In plain terms: The implant turns excess sugar into a compound the body can excrete, rather than relying on insulin to clear sugar from the blood.
How does the implant know when to work?
A wearable glucose monitor detects high blood sugar and sends readings through a smartphone, which switches the implant on. When blood glucose returns to a safer range, the phone switches the implant off. This automatic setup ran for two weeks in eight mice.
In plain terms: The implant follows glucose readings and adjusts its activity without a person deciding when to turn it on.
Why does avoiding insulin matter?
Diabetes affects about 830 million people worldwide. Conventional type 2 diabetes treatments, including insulin and GLP-1 drugs, require careful dosing. Even experimental diabetes-controlling implants still rely on insulin, according to Fussenegger, a bioengineer at ETH Zurich.
The new system takes a different route: it removes glucose from the body without added drugs, genes or living cells. That design could someday offer a drug-free option for type 2 diabetes and obesity, though human benefit remains unproven.
In plain terms: The proposed approach aims to remove glucose from the body, not merely clear it from the bloodstream.
Can the implant work safely in people?
David Klonoff, an endocrinologist at Sutter Mills-Peninsula Medical Center in Burlingame, California, was not involved in the study. He said: “This is a potentially promising method. But the risks are significant and must be carefully ruled out before it can be safely tested on humans.”
Researchers need to determine how much gluconate the kidneys can clear. If it accumulates, it could disrupt the body's acid-base balance, meaning its balance between acidic and alkaline conditions, and cause nausea or confusion. Excreting it could also deplete electrolytes such as sodium and potassium, Klonoff said.
Human scale presents another obstacle. People consume about 250 grams of carbohydrates daily, compared with two grams for mice, Klonoff estimates. Meeting that demand might require a much larger implant or several devices.
In a lab test, a larger device cleared nearly all glucose from about 5 liters of solution, roughly an adult's blood volume, though not a full day's glucose intake.
Fussenegger's team plans to test the device in pigs and sheep before considering human trials. If it proves safe and effective, it could offer an alternative to existing diabetes treatments and a new weight-loss option for people with or without diabetes.
In plain terms: Animal studies must resolve kidney safety and human-scale capacity before researchers can test the implant in people.
via sciencenews.org (Source)
More from Elena Vasquez
Show full bio
Correspondent covering money, funding and market shifts around general science news at SciBeat.
384 articles
Nearby plates
- Electric Implant Cuts Blood Sugar Without Drugs — In Mice, So Far
- Implant Converts Blood Sugar Into Harmless Byproduct in Diabetes Breakthrough
- Early Trial: Some Type 1 Diabetes Patients Off Insulin
- Strict blood sugar targets may quietly erode daily well-being
- All 12 Trial Participants Off Insulin After Tegoprubart Treatment